Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q4 2023 vs. Q3 2023

How the institutions holding Curis Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of CRIS: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3638+2
Shares2.13M2.05M−78.1K (−3.7%)
Value$14.0M$26.1M+$12.1M (+86.4%)

New holders (7)

Institutions that held Curis Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to CRIS in Q4 2023
InstitutionSharesValue% of portfolio
Northern Trust Corp15,664$199.7K0.00%
LPL Financial LLC12,082$154.0K0.00%
a16z Perennial Management, L.P.6,653$84.8K0.01%
Natixis500$6.38K0.00%
LM Advisors LLC200$2.55K0.00%
Harbour Investments, Inc.58$7400.00%
Vima LLC3$380.00%

Sold out (5)

Institutions that held Curis Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of CRIS in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Alyeska Investment Group, L.P.78,135$514.9K
Millennium Management LLC23,716$156.3K
Two Sigma Advisers, LP22,129$145.8K
Cutler Group LP220$1.00K
WR Wealth Planners, LLC1$7